secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2026-05-22T10:03:29+00:00
Accession:  0001493152-26-024884
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology shareholders re-elect two directors, ratify Grant Thornton at 2026 annual meeting
--------------------------------------------------------------------------------

- Stockholders voted to re-elect Louie Ngar Yee (16.7M for, 8.8M withheld) and Steven Chaouki (25.1M for, 345.7K withheld) as Class I directors for three-year terms.
- Ratification of Grant Thornton LLP as independent auditor for FY 2026 passed with 37.3M for, 210K against, 19K abstentions.
- Approximately 61.9% of outstanding shares (37.5M of 60.7M) were represented at the meeting, establishing a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315226024884/0001493152-26-024884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315226024884/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-024884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer